Abstract
Currently, no consistent evidence-based guidelines for the management of synchronous bilateral breast cancer (SBBC) exist and it is uncertain how presenting with SBBC affects patients’ prognosis. We conducted a review of studies analyzing the association between SBBC and prognosis. The studies that reported adjusted effect measures were included in meta-analyses of effect of bilaterality on breast cancer mortality. From 57 initially identified records 17 studies from 11 different countries including 8,050 SBBC patients were included. The quality of the studies varied but was generally low with small sample sizes, and lack of consistent, detailed histo-pathological information. When doing meta-analysis on the subgroup of studies that provided adjusted effect estimates on breast cancer mortality (nine studies including 3,631 SBBC cases), we found that bilaterality in itself had a negative impact on prognosis after adjustment for known prognostic factors (pooled HR 1.37, 95 % CI 1.24–1.50, p < 0.0001). Multiple sensitivity analyses indicated robustness of the overall estimate. This review summarizes the current evidence of the association between SBBC and prognosis. The previously accepted convention that appropriate adjuvant treatment can be determined by considering the higher risk cancer was not confirmed in this review; rather it seems that being diagnosed with two tumors simultaneously entails a worse prognosis above and beyond that of the unilateral cancers of the same stage. To determine the true association between SBBC and breast cancer prognosis, studies of large and updated samples of SBBC should be done and include thorough histo-pathologic information.
Similar content being viewed by others
References
Nichol AM, Yerushalmi R, Tyldesley S et al (2011) A case-match study comparing unilateral with synchronous bilateral breast cancer outcomes. J Clin Oncol 29(36):4763–4768
Verkooijen HM, Chatelain V, Fioretta G et al (2007) Survival after bilateral breast cancer: results from a population-based study. Breast Cancer Res Treat 105(3):347–357
Renz DM, Bottcher J, Baltzer PA et al (2010) The contralateral synchronous breast carcinoma: a comparison of histology, localization, and magnetic resonance imaging characteristics with the primary index cancer. Breast Cancer Res Treat 120(2):449–459
Irvine T, Allen DS, Gillett C, Hamed H, Fentiman IS (2009) Prognosis of synchronous bilateral breast cancer. Br J Surg 96(4):376–380
Hartman M, Czene K, Reilly M et al (2005) Genetic implications of bilateral breast cancer: a population based cohort study. Lancet Oncol 6(6):377–382
Imyanitov EN, Cornelisse CJ, Devilee P (2007) Searching for susceptibility alleles: emphasis on bilateral breast cancer. Int J Cancer 121(4):921–923
Antoniou AC, Easton DF (2003) Polygenic inheritance of breast cancer: implications for design of association studies. Genet Epidemiol 25:190–192
Hartman M, Czene K, Reilly M et al (2007) Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol 25(27):4210–4216
Quan G, Pommier SJ, Pommier RF (2008) Incidence and outcomes of contralateral breast cancers. Am J Surg 195(5):645–650
Schwentner L, Wolters R, Wischnewsky M, Kreienberg R, Wockel A (2012) Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients. Breast 21(2):171–177
Jobsen JJ, van der Palen J, Ong F, Meerwaldt JH (2003) Synchronous, bilateral breast cancer: prognostic value and incidence. Breast 12(2):83–88
Polednak AP (2003) Bilateral synchronous breast cancer: a population-based study of characteristics, method of detection, and survival. Surgery 133(4):383–389
McCaul K (2006) Bilateral breast cancer incidence and survival, Thesis (PhD). School of Population Health and Clinical Practice, University of Adelaide. http://hdl.handle.net/2440/37870. Accessed 13 Dec 2013
Beckmann KR, Buckingham J, Craft P et al (2011) Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort. Breast 20(2):158–164
Shi YX, Xia Q, Peng RJ et al (2012) Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer. J Cancer Res Clin Oncol 138(4):705–714
Roder D, de Silva P, Zorbas H et al (2012) Survival from synchronous bilateral breast cancer: the experience of surgeons participating in the breast audit of the Society of Breast Surgeons of Australia and New Zealand. Asian Pac J Cancer Prev 13(4):1413–1418
Gollamudi SV, Gelman RS, Peiro G et al (1997) Breast-conserving therapy for stage I–II synchronous bilateral breast carcinoma. Cancer 79(7):1362–1369
Schmid SM, Pfefferkorn C, Myrick ME et al (2011) Prognosis of early-stage synchronous bilateral invasive breast cancer. Eur J Surg Oncol 37(7):623–628
de la Rochefordiere A, Asselain B, Scholl S et al (1994) Simultaneous bilateral breast carcinomas: a retrospective review of 149 cases. Int J Radiat Oncol Biol Phys 30(1):35–41
Higgins J, Thompson S, Deeks J, Altman D (2002) Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 7(1):51–61
Diaz R, Munarriz B, Santaballa A, Palomar L, Montalar J (2012) Synchronous and metachronous bilateral breast cancer: a long-term single-institution experience. Med Oncol 29(1):16–24
Hungness ES, Safa M, Shaughnessy EA et al (2000) Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts. Surgery 128(4):702–707
Beinart G, Gonzalez-Angulo AM, Broglio K et al (2007) Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival. Clin Breast Cancer 7(11):867–874
Kollias J, Ellis IO, Elston CW, Blamey RW (2001) Prognostic significance of synchronous and metachronous bilateral breast cancer. World J Surg 25(9):1117–1124
Sobin LH, Gospodarowicz MK, Wittekind C (2013) International Union Against Cancer (UICC) TNM Classification of Malignant Tumors, 7th edn. Wiley-Blackwell, Oxford
Kwast AB, Liu L, Roukema JA et al (2012) Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer. Br J Cancer 107(3):549–555
Imyanitov EN, Hanson KP (2003) Molecular pathogenesis of bilateral breast cancer. Cancer Lett 191(1):1–7
Iyevleva AG, Kuligina ES, Mitiushkina NV, Togo AV, Miki Y, Imyanitov EN (2012) High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas. Breast Cancer Res Treat 131(3):1049–1059
Acknowledgments
The authors would like to thank Timothy SH Mak (PhD) for statistical assistance and valuable comments in preparation of the manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Holm, M., Tjønneland, A., Balslev, E. et al. Prognosis of synchronous bilateral breast cancer: a review and meta-analysis of observational studies. Breast Cancer Res Treat 146, 461–475 (2014). https://doi.org/10.1007/s10549-014-3045-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-014-3045-0